AzTrials
AzTrials

CyberchondriaNCT07192354

The Relationship Between Cyberchondria and Health Perception and Anxiety Level in Pregnant Women: A Cross-sectional Study

An observational study of Cyberchondria and Pregnancy, run by Karabuk University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pregnancy is a unique period in which women require extensive health information both to protect their own health and to prepare for motherhood. The literature indicates that pregnant women most frequently seek information on healthy nutrition, physical activity, fetal development, pregnancy symptoms, childbirth… Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Cyberchondria, Pregnancy
What is being tested?
Questionnaire and Physical Exam
How many people
166 participants
Where
1 siteTurkey (Türkiye)
Study dates
27 Oct 2025to 30 Jan 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: pregnant women

Who may be able to join

  • Must be 18 years or older, pregnant, have access to the internet at any time, and have the ability to use it.
  • Must be proficient in Turkish to understand the scales.

Who cannot join

  • Having a diagnosed psychiatric illness,
  • Being a healthcare worker,
  • Having cognitive impairment or mental or physical limitations to the extent that they cannot understand questions.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Karabuk University

    Karabük

Other trials in Turkey (Türkiye)

About this study

Pregnancy is a unique period in which women require extensive health information both to protect their own health and to prepare for motherhood. The literature indicates that pregnant women most frequently seek information on healthy nutrition, physical activity, fetal development, pregnancy symptoms, childbirth preparation, vaccination, and medication use. Although health professionals are considered reliable sources of information, due to limited accessibility, pregnant women often turn to the internet and social media. This increases the risk of exposure to inaccurate or incomplete information and may sometimes lead to cyberchondria. Moreover, during pregnancy, factors such as educational level, socioeconomic conditions, and family relationships contribute to the frequent occurrence of anxiety disorders, which can negatively affect the mother's quality of life and fetal development. Health perception, on the other hand, is an important concept that shapes individuals' health behaviors and responsibilities. However, studies examining the relationship between cyberchondria, anxiety levels, and health perception in pregnant women are limited. This study aims to reveal the relationship between health information-seeking behaviors, health perception, and anxiety levels in this special population of pregnant women.

Being tested
Questionnaire and Physical Exam

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Questionnaire and Physical ExamOther

    Participants will be administered the Cyberchondria Severity Scale Short Form (CSS-12), Health Perception Scale, and State and Trait Anxiety Scale online via Google form.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Cyberchondria Severity Scale

    The Cyberchondria Severity Scale (CSS) was originally developed by McElroy and Shevlin (2014) to evaluate cyberchondria, defined as a form of anxiety characterized by excessive health-related information seeking on the internet. Subsequently, McElroy et al. (2019) introduced the short form of the scale, the CSS-12. The Turkish adaptation, validity, and reliability study of the CSS-12 was conducted by Söyler et al. (2021).

    The CSS-12 consists of 12 items, each rated on a 5-point Likert-type scale ranging from 1 ("never") to 5 ("always"). Total scores are calculated by summing all item responses, with possible scores ranging from 12 to 60. Higher scores indicate greater severity of cyberchondria. The scale does not contain any reverse-coded items. The CSS-12 comprises four subdimensions: excessiveness, distress, reassurance-seeking, and compulsion.

    Measured: 1 month

  2. The Health Perception Scale

    The Health Perception Scale (HPS) was developed by Diamond et al. in 2007 to assess individuals' perceptions of their own health. The Turkish adaptation, including validity and reliability testing, was conducted by Kadıoğlu et al. in 2012. The scale consists of 15 items rated on a 5-point Likert-type scale, with response options ranging from "Strongly Disagree" to "Strongly Agree." Negative items are reverse-coded (Strongly Disagree = 5 to Strongly Agree = 1). The scale includes four subdimensions: central control, self-awareness, certainty, and importance of health. Total scores range from 15 to 75, with higher scores reflecting a more positive health perception. Participants indicate their agreement with each item, allowing researchers to quantify their overall health perception and examine its relationship with other psychosocial variables.

    Measured: 1 month

  3. State-Trait Anxiety Inventory

    The State-Trait Anxiety Inventory (STAI) was originally adapted into Turkish by Öner and Le Compte between 1974 and 1977 to evaluate anxiety levels in both adolescent and adult Turkish populations. The inventory is widely used in research involving young and adult groups. The State Anxiety Scale items assess the intensity of feelings or behaviors in response to specific situations, with responses rated on a 4-point scale: 1 = Not at all, 2 = Somewhat, 3 = Much, 4 = Completely. The Trait Anxiety Scale items evaluate the frequency of feelings or behaviors over time, with response options: 1 = Almost never, 2 = Sometimes, 3 = Often, 4 = Almost always. The State Anxiety Scale consists of both direct items (3, 4, 6, 7, 9, 12, 13, 14, 17, 18) and reverse-scored items (1, 2, 5, 8, 10, 11, 15, 16, 19, 20). Similarly, the Trait Anxiety Scale includes direct items (22, 23, 24, 25, 28, 29, 31, 32, 34, 35, 37, 38, 40) and reverse-scored items (21, 26, 27, 30,

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Sep 2025
  2. Study start27 Oct 2025
  3. Primary completion30 Dec 2025
  4. Study completion30 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
166 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07192354
Sponsor's protocol ID
KBUPTherapy
Status last verified
May 2026
First submitted
17 Sep 2025
Last updated
28 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cyberchondria and Pregnancy, run by Karabuk University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Cyberchondria Severity Scale (time frame: 1 month). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 May 2026; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in